Fig. 3From: Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the headBox and whisker plot of NTCP (%) comparison for gastrointestinal OARs (Stomach, duodenum, small bowel, and stoduo) using Pan et al., Burman et al., Holyoake et al., LKB model parameters between IMRT and ro-IMPT treatment plansBack to article page